NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Check-Cap Ltd (NASDAQ: CHEK)
CHEK Technical Analysis
4
As on 9th Jun 2023 CHEK STOCK Price closed @ 2.50 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.40 & Strong Buy for SHORT-TERM with Stoploss of 0.59 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CHEKSTOCK Price
Open | 2.70 | Change | Price | % |
High | 2.91 | 1 Day | -0.09 | -3.47 |
Low | 2.46 | 1 Week | 1.00 | 66.67 |
Close | 2.50 | 1 Month | 1.14 | 83.82 |
Volume | 212900 | 1 Year | 1.82 | 267.65 |
52 Week High 5.78 | 52 Week Low 0.23 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
CHEK Daily Charts |
CHEK Intraday Charts |
Whats New @ Bazaartrend |
CHEK Free Analysis |
|
CHEK Important Levels Intraday
RESISTANCE | 3.37 |
RESISTANCE | 3.09 |
RESISTANCE | 2.92 |
RESISTANCE | 2.75 |
SUPPORT | 2.25 |
SUPPORT | 2.08 |
SUPPORT | 1.91 |
SUPPORT | 1.63 |
CHEK Forecast May 2024
4th UP Forecast | 3.02 |
3rd UP Forecast | 2.85 |
2nd UP Forecast | 2.75 |
1st UP Forecast | 2.65 |
1st DOWN Forecast | 2.35 |
2nd DOWN Forecast | 2.25 |
3rd DOWN Forecast | 2.15 |
4th DOWN Forecast | 1.98 |
CHEK Weekly Forecast
4th UP Forecast | 2.87 |
3rd UP Forecast | 2.75 |
2nd UP Forecast | 2.68 |
1st UP Forecast | 2.60 |
1st DOWN Forecast | 2.40 |
2nd DOWN Forecast | 2.32 |
3rd DOWN Forecast | 2.25 |
4th DOWN Forecast | 2.13 |
CHEK Forecast2024
4th UP Forecast | 13.43 |
3rd UP Forecast | 9.92 |
2nd UP Forecast | 7.76 |
1st UP Forecast | 5.59 |
1st DOWN Forecast | -0.59 |
2nd DOWN Forecast | -2.76 |
3rd DOWN Forecast | -4.92 |
4th DOWN Forecast | -8.43 |
Check-Cap Ltd ( NASDAQ USA Symbol : CHEK )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CHEK Other Details
Segment | EQ | |
Market Capital | 85945056.00 | |
Sector | Healthcare | |
Industry | Diagnostics & Research | |
Offical website | > echo $website ; ?> |
CHEK Address
CHEK Latest News
CHEK Business Profile
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based system that utilizes low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule, which is designed to measure, collect, and transmit structural information; C-Scan Track, a disposable system attached to the patient's back via biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis and report generation. The company was founded in 2004 and is based in Isfiya, Israel. Address: Check-Cap Building, Isfiya, Israel, 30090
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service